Hot Stock Alerts


Potential Breakout Stocks of the Day:


Best Stocks in 2014 - RDNT VRS GRBK
Best Penny Stocks in 2014 - ISR IBIO DPW
Today's Biggest Gainers - Hot Stocks - TWTR
Top Stocks 2015 - TWTR YELP NDLS
Top Penny Stocks 2015 - RNN MNGA PHOT
Shale Stocks - http://oilshalegas.com

Receive My Best Current Trading Ideas - Premium Room

Stock Market Closing Report - 11/26/14 - November 26, 2014


Wednesday, June 24, 2009

Jazz Pharmaceuticals JAZZ Stock News 6/25/09

Jazz Pharmaceuticals, Inc. (JAZZ) stock is soaring afterhours tonight ( 6/24/09 ) on the following news. $4.02 Up 24%. Expect the stock to be very active on June 25, 2009

Discuss Stocks - http://stockstobuy.org

Jazz Pharmaceuticals and UCB Announce Second Phase III Study of Sodium Oxybate in Patients With Fibromyalgia Meets Primary Endpoints

Preliminary top-line results of second Phase III study show highly significant decreases in pain and fatigue and improved daily function in fibromyalgia patients and confirm results from the first Phase III study

PALO ALTO, Calif., and BRUSSELS, June 24, 2009 /PRNewswire-FirstCall via COMTEX/ -- press release, regulated information -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) and UCB (Euronext Brussels: UCB) announced today positive preliminary top-line results from the second of two Phase III clinical trials of sodium oxybate (JZP-6) for the treatment of fibromyalgia. Confirming the positive results from the first Phase III study, this international, placebo-controlled trial of sodium oxybate to treat fibromyalgia achieved its key endpoints. As in the first randomized, double-blind fibromyalgia study, sodium oxybate significantly decreased pain and fatigue and improved daily function and patient global impression of change. Sodium oxybate has not been evaluated by regulators for the treatment of fibromyalgia and is not approved for this use.

"Fibromyalgia is a chronic illness, characterized by widespread pain, unrefreshing sleep, chronic fatigue, and psychological distress," said I. Jon Russell, M.D., Ph.D., lead investigator in the first Phase III study and Associate Professor of Medicine, Division of Clinical Immunology and Rheumatology, and Director, University Clinical Research Center, University of Texas Health Science Center at San Antonio. "Sodium oxybate has shown a positive effect on a number of the symptoms of fibromyalgia, and thus could have a significant impact on patients' quality of life."

Full Article Here

For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free